CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
PensionPosition in CAPR — Capricor Therapeutics, Inc.
CIK 1081019
WEST SACRAMENTO, CA
Position in CAPR
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,967,366
+$1,898,968 QoQ
Shares Held
64,716
+2630.6% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM holds $855,427,423 across 222 Biotechnology names. CAPR ranks #67 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
373,481 | $166,774,205 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
154,201 | $119,141,860 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
196,863 | $65,136,060 | |
| 4 | INSM |
INSMED Inc
|
303,182 | $49,576,320 | |
| 5 | RPRX |
Royalty Pharma plc
|
759,042 | $36,411,244 | |
| 6 | INCY |
Incyte Corp
|
241,287 | $22,709,932 | |
| 7 | MRNA |
Moderna, Inc.
|
407,190 | $20,685,252 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
165,277 | $16,073,188 |
All Filings in CAPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,967,366 | 64,716 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $68,398 | 2,370 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,282 | 2,397 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $320,113 | 32,237 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $305,929 | 32,237 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $444,870 | 32,237 | Shares | Sole | 2025-03-18 | |
| 2024-09-30 | $27,971 | 1,839 | Shares | Sole | 2025-04-04 | |
| 2024-06-30 | $8,772 | 1,839 | Shares | Sole | 2025-04-08 | |
| No filing history on record for this holder in this stock. | ||||||